$2.55
-0.04[-1.54%]
Last update: 8:32AM Get Real Time Here
OncoCyte reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of OncoCyte using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | AM | OCX | Q1 | -$1.40 | -$0.76 | — | — | $297.00K | $250.00K | — | — | Get Alert |
04/12/2024 | AM | OCX | Q4 | — | -$1.14 | -$2.18 | -91.23% | — | $320.00K | $314.00K | -1.88% | Get Alert |
11/09/2023 | AM | OCX | Q3 | -$1.60 | -$1.01 | -$0.50 | 50.50% | $1.02M | $330.00K | $429.00K | 30.00% | Get Alert |
08/10/2023 | AM | OCX | Q2 | -$2.00 | -$0.87 | -$0.59 | 32.18% | $2.07M | $360.00K | $463.00K | 28.61% | Get Alert |
05/11/2023 | AM | OCX | Q1 | -$2.40 | -$1.60 | -$1.40 | 1250.00% | $1.43M | $350.00K | $297.00K | -15.14% | Get Alert |
04/03/2023 | AM | OCX | Q4 | -$1.20 | -$1.80 | — | — | $3.59M | $1.42M | — | — | Get Alert |
11/10/2022 | PM | OCX | Q3 | — | -$2.20 | -$1.60 | 2727.27% | — | $1.48M | $1.02M | -31.28% | Get Alert |
08/10/2022 | PM | OCX | Q2 | -$2.40 | -$2.20 | -$2.00 | 909.09% | $2.03M | $2.70M | $2.07M | -23.44% | Get Alert |
05/11/2022 | PM | OCX | Q1 | -$1.00 | -$2.40 | -$2.20 | 833.33% | $1.12M | $2.24M | $1.43M | -36.38% | Get Alert |
03/10/2022 | PM | OCX | Q4 | -$1.80 | -$2.60 | -$1.20 | 5384.62% | $503.00K | $3.63M | $3.59M | -1.13% | Get Alert |
11/09/2021 | PM | OCX | Q3 | -$1.00 | -$2.40 | -$2.00 | 1666.67% | $555.00K | — | $984.00K | — | Get Alert |
08/10/2021 | PM | OCX | Q2 | — | -$2.00 | -$2.60 | -3000.00% | — | $1.57M | $2.03M | 29.30% | Get Alert |
05/17/2021 | PM | OCX | Q1 | -$2.60 | -$2.00 | -$1.00 | 5000.00% | $16.00K | $830.00K | $1.12M | 35.42% | Get Alert |
03/16/2021 | PM | OCX | Q4 | -$3.00 | -$2.20 | -$1.80 | 1818.18% | $0.00 | $820.00K | $503.00K | -38.66% | Get Alert |
11/12/2020 | PM | OCX | Q3 | -$2.00 | -$1.80 | -$2.00 | -1111.11% | $0.00 | $370.00K | $555.00K | 50.00% | Get Alert |
07/29/2020 | PM | OCX | Q2 | -$2.00 | -$2.00 | -$2.80 | -4000.00% | $0.00 | $50.00K | $143.00K | 186.00% | Get Alert |
05/12/2020 | PM | OCX | Q1 | -$1.60 | -$2.20 | -$2.60 | -1818.18% | $0.00 | — | $16.00K | — | Get Alert |
03/25/2020 | PM | OCX | Q4 | -$2.20 | -$1.80 | -$3.00 | -6666.67% | $0.00 | — | $0.00 | — | Get Alert |
11/14/2019 | PM | OCX | Q3 | -$1.40 | -$1.80 | -$2.00 | -1111.11% | $0.00 | — | $0.00 | — | Get Alert |
OncoCyte (OCX) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on April 12, 2024 for Q4.
The Actual EPS was $-2.18, which missed the estimate of $-1.14.
The Actual Revenue was $314K, which missed the estimate of $320K.
Browse earnings estimates, EPS, and revenue on all stocks.